About Us

Cisbio Bioassays is a privately held life sciences company committed to improving human healthcare.  With more than 30 years of experience in in vitro diagnostics and drug discovery, we provide creative technological solutions and partnerships to the global scientific community. Our portfolio of over 460 proprietary assays and reagents is used by pharmaceutical, biotechnology, academia and contract research organizations worldwide to help generate effective therapies.

Research innovation

Cisbio Bioassays began as a developer of immunoassays.  In the 1990s, we combined this know-how with Nobel prize-winning chemistry research to create Homogeneous Time Resolved Fluorescence (HTRF®), a breakthrough technology whose advanced properties continue to enhance and accelerate the drug discovery process.  Our R&D teams — both in-house and in collaboration with industrial and academic research partners — regularly expand HTRF’s field of applications through new tools that help us all to understand biological functions better.

Our commitment to service

Cisbio Bioassays has facilities in France, the United States and China, as well as a network of sales offices and distributors across the globe.  Our relationship with customers is at the core of our activity, and we provide a hands-on approach and collaborative products that contribute to successful drug discovery research projects in every major market. 

Our in-house and field-based staff of scientific consultants combines a variety of disciplines – from chemistry to molecular and cellular biology – to offer skilled technical services and support on assay development, technology education, assay implementation, new applications, overcoming unique challenges, strategic thinking and assay conceptualization.

Through our dedication to innovation in technologies, products and associated services, Cisbio Bioassays will continue to respond to the as-yet unmet technical needs of customers, as well as to the existing and future medical concerns of a global patient base.